Skip to content
Menu

Neurocrine Biosciences, Inc. NBIX

Full chart Compare
Set alert

Price alert · NBIX

All alert types
165.92 USD +0.61 (+0.37%)

Regular-session close

165.92 0.00 0.00%

After hours · Nov 17, 5:27 PM ET

161.99 Day range 166.25
122.14 52-week range 186.12
YTD
+16.99%
1 year
+15.58%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Other Income$86.30MGross Profit$2.81BCost of Revenue$52.10MGross Profit & Other Income$2.89BNet Income$478.60MSelling, General & Admin$1.16BResearch & Development$1.02BOther Operating Expenses$17.40MIncome Tax$226.80MRevenue$2.86BProduct$2.83BCollaboration Revenue$26.60M

Latest period ending Dec 31, 2025 · select a line to chart its full history

NBIX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.86B2.36B1.89B1.49B1.13B
2.81B2.32B1.85B1.47B1.12B
619.10M570.50M250.90M249.00M102.50M
478.60M341.30M249.70M154.50M89.60M
4.673.292.471.560.92
NBIX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
713.00M233.00M251.10M262.90M340.80M
4.63B3.72B3.25B2.37B2.07B
1.38B1.13B1.02B660.90M698.50M
415.30M455.10M428.40M262.90M440.40M
3.25B2.59B2.23B1.71B1.37B
NBIX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
782.70M595.40M389.90M339.40M256.50M
-264.40M-126.80M-467.10M-177.10M-130.20M
-38.30M-486.70M65.30M-234.30M27.40M
-34.00M-38.20M-28.30M-16.50M-23.40M
480.00M-18.10M-11.60M-73.30M153.70M